Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: software salesperson who wrote (2891)	7/29/2013 4:10:26 PM
From: scaram(o)uche	1 Recommendation Recommended By Biotech Jim Respond to of 3202

Thanks, Sales! That would make the B cell bit a tad more straight-forward. ;-) Best! Rick edit: their comment "Recall that we have been following this undisclosed compound since last year, when grants we found online suggested that it was teed up for a B-cell malignancy study" indicates that they had long ago found the Univ. Michigan pointer. Good job, Wells Fargo/Abrahams!